[1] HE G, WANG X, LIU W, et al.Chemical Constituents, Pharmacological Effects, Toxicology, Processing and Compatibility of Fuzi (Lateral Root of Aconitum Carmichaelii Debx): a Review[J]. J Ethnopharmacol, 2023, 10(307): 116160. [2] LI CF, PING J, YAO PY, et al.Research Progress on the Cardiotoxicity of Traditional Chinese Medicine and Its Detoxification Measures[J]. Modern Chinese Medicine(现代中医药), 2023, 43(2): 13-19. [3] JIANG H, ZHANG Y, ZHANG Y, et al. An Updated Meta-Analysis Based on the Preclinical Evidence of Mechanism of Aconitine-Induced Cardiotoxicity[J]. Front Pharmacol, 2022, 8, 13: 900842. [4] ZHANG S, YANG H, CHEN SQ, et al.Research Progress on Toxicity and Toxicokinetics of Chinese Drugs of Aconitum[J]. Chinese Archives of Traditional Chinese Medicine(中华中医药学刊), 2024, 42(8): 232-236. [5] MJØLSTAD OC, RADTKE M, BRODTKORB E, et al. Recurrent Malignant Ventricular Arrhythmias and Paresthesia-a Mystery Revealed as Aconitine Poisoning: a Case Report[J]. J Med Case Rep, 2023, 17(1): 554. [6] LIANG XY, SHI YJ, LIU YC, et al.Research Progress on Pharma-cological Mechanism and Attenuation and Synergism of Aconite[J]. Global Traditional Chinese Medicine(环球中医药), 2024, 17(7): 1428-1439. [7] Chinese Pharmacopoeia Commission.Pharmacopoeia of the People’s Republic of China, Volume I(中华人民共和国药典一部)[M]. Beijing: China Medical Science Press, 2020. [8] XIANG G, GUO S, QIN J, et al.Comprehensive Insight into the Pharm-acology, Pharmacokinetics, Toxicity, Detoxification and Extraction of Hypaconitine from Aconitum Plants[J]. J Ethnopharmacol, 2024, 1(321): 117505. [9] LI ZY, TAN P, SUN JN, et al.Effects of Hypaconitine on Ca2+ Concentration and Expression of Cx43 in Myocardial Cells[J]. Shi Zhen Journal of Traditional Chinese Medicine and Pharmacy(时珍国医国药), 2011, 22(11): 2689-2691. [10] LIU H, ZHONG LY, DENG YW, et al.Analysis on Chemical Constituents and Toxicity of Sini Decoction of Different Aconiti Lateralis Radix Praeparata Processed Products[J]. Chinese Traditional and Herbal Drugs(中草药), 2023, 54(5): 1397-1410. [11] HARCHI EA, BRINCOURT O.Pharmacological Activation of the hERG K+ Channel for the Management of the Long QT Syndrome: a Review[J]. J Arrhythm, 2022, 38(4): 554-569. [12] ZHANG CH, SHEN CH, RAN Q, et al.Optical Mapping Technology to Evaluate the Dose Relationship of Aconitine Cardiotoxicity[J]. Chinese Journal of Modern Applied Pharmacy(中国现代应用药学), 2024, 41(12): 1631-1637. [13] CHEN L, SAMPSON KJ, KASS RS.Cardiac Delayed Rectifier Potassium Channels in Health and Disease[J]. Card Electrophysiol Clin, 2016, 8(2): 307-322. [14] JOUKAR S.A Comparative Review on Heart Ion Channels, Action Potentials and Electrocardiogram in Rodents and Human: Extrapolation of Experimental Insights to Clinic[J]. Lab Anim Res, 2021, 37(1): 25. [15] SONG T, LI J, WANG M, et al.Analysis of Resibufogenin on Cardiac Conduction Reveals a Species Difference in the Cardiac Electrophysiology: Rats Versus Guinea Pigs[J]. Biomed Pharmacother, 2021, 139: 111581. [16] ROCHE O, TRUBE G, ZUEGGE J, et al.A Virtual Screening Method for Prediction of the HERG Potassium Channel Liability of Compound Libraries[J]. Chembiochem, 2002, 3(5): 455-459. [17] SUN HY, XING HY, ZHAO Q, et al.Effects of Nine Clinical Drugs with Different Cardiovascular Risks on hERG Potassium Channels[J]. Journal of Nanjing Medical University (Natural Science Edition)(南京医科大学学报), 2019, 39(1): 1-9. [18] SMITH JL, MCBRIDE CM, NATARAJ PS, et al.Trafficking-Deficient hERG K+ Channels Linked to Long QT Syndrome are Regul-ated by a Microtubule-Dependent Quality Control Compartment in the ER[J]. Am J Physiol Cell Physiol, 2011, 301(1): C75-C85. [19] ZHAN G, WANG F, DING YQ, et al.Rutaecarpine Targets hERG Channels and Participates in Regulating Electrophysiological Properties Leading to Ventricular Arrhythmia[J]. J Cell Mol Med, 2021, 25(11): 4938-4949. [20] CHEN J, SROUBEK J, KRISHNAN Y, et al.PKA Phosphorylation of HERG Protein Regulates the Rate of Channel Synthesis[J]. Am J Physiol Heart Circ Physiol, 2009, 296(5): H1244-H1254. |